still holding these
Neonc Tech
NTHI----
Neonc Tech (NTHI)
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Neonc Tech Analyst Rating
View moreForecast & Rating
Sep 28, 2026Price forecast
$17.00419.88%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- benzinga_article ·
12 Health Care Stocks Moving In Friday's Intraday Session
- Market Movers ·
NeOnc Technologies surges 17% on Abu Dhabi oncology pact and patient data
- StockTitan ·
NeOnc Breaks Through Key Levels, as Brain-Cancer Stock’s Catalysts Continue | NTHI Stock News
- Tip Ranks ·
NeOnc Technologies Expands Abu Dhabi Oncology Collaboration Efforts
- StockTitan ·
NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight | NTHI Stock News
Posts
View moreBullish vs. Bearish — Last 3 Months
101 followers · 0 opinions
▲Bullish50%
50%Bearish▼